<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04759183</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00022194</org_study_id>
    <secondary_id>NCI-2021-00794</secondary_id>
    <secondary_id>STUDY00022194</secondary_id>
    <nct_id>NCT04759183</nct_id>
  </id_info>
  <brief_title>Virtual Reality Experiences for Anxiety and Pain Control</brief_title>
  <official_title>Impact of Different Virtual Reality Experiences on Anxiety and Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OHSU Knight Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>OHSU Knight Cancer Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies the impact of virtual reality experiences on anxiety before surgery and&#xD;
      pain after surgery. The goal of this study is to examine how different virtual reality&#xD;
      experiences may help reduce anxiety and improve pain control, which may help reduce the need&#xD;
      for medications such as opioids.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To measure the impact of a gaming virtual reality (VR) experience compared to a&#xD;
      mindfulness VR experience on preoperative anxiety and postoperative pain.&#xD;
&#xD;
      OUTLINE: Patients are randomized to 1 of 2 arms.&#xD;
&#xD;
      ARM I: Patients participate in a VR intervention (Angry Birds) over 15 minutes before&#xD;
      standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes&#xD;
      after surgery.&#xD;
&#xD;
      ARM II: Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of&#xD;
      care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after&#xD;
      surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in preoperative anxiety scores</measure>
    <time_frame>Baseline up to pre surgery (estimated 1 day)</time_frame>
    <description>Assessed by visual analogue scale (VAS) from 0-100mm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in postoperative pain scores</measure>
    <time_frame>Baseline after surgery up to study completion (estimated 1 day)</time_frame>
    <description>Assessed by VAS scale from 0-100mm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>immediately before intervention, and then immediately after intervention (estimated 1 day)</time_frame>
    <description>mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient enjoyment of each VR experience</measure>
    <time_frame>Up to study completion (estimated 1 day)</time_frame>
    <description>Likert scale (1-5). 1 represents the lowest score, and 5 represents the highest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in heart rate</measure>
    <time_frame>immediately before intervention, and then immediately after intervention (estimated 1 day)</time_frame>
    <description>beats per minute (bpm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient desire to use VR more in their healthcare</measure>
    <time_frame>Up to study completion (estimated 1 day)</time_frame>
    <description>Likert scale (1-5). 1 represents the lowest score, and 5 represents the highest.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hematopoietic and Lymphoid Cell Neoplasm</condition>
  <condition>Malignant Solid Neoplasm</condition>
  <arm_group>
    <arm_group_label>Arm I (Angry Birds, TRIPP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients participate in a VR intervention (Angry Birds) over 15 minutes before standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (TRIPP, Angry Birds)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (Angry Birds, TRIPP)</arm_group_label>
    <arm_group_label>Arm II (TRIPP, Angry Birds)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Virtual Reality Game</intervention_name>
    <description>Participate in VR Game &quot;Angry Birds&quot;</description>
    <arm_group_label>Arm I (Angry Birds, TRIPP)</arm_group_label>
    <arm_group_label>Arm II (TRIPP, Angry Birds)</arm_group_label>
    <other_name>VR Game</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Virtual Reality Meditation</intervention_name>
    <description>Participate in VR Meditation &quot;TRIPP&quot;</description>
    <arm_group_label>Arm I (Angry Birds, TRIPP)</arm_group_label>
    <arm_group_label>Arm II (TRIPP, Angry Birds)</arm_group_label>
    <other_name>VR Meditation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (18 years or older and younger than 89)&#xD;
&#xD;
          -  Able to consent&#xD;
&#xD;
          -  English-speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-English speaking patients because the VR content is only available in English&#xD;
&#xD;
          -  Have symptoms concerning for an active respiratory infection or are on contact or&#xD;
             isolation precautions&#xD;
&#xD;
          -  Any active eye discharge&#xD;
&#xD;
          -  A history of seizure, epilepsy, or hypersensitivity to flashing light&#xD;
&#xD;
          -  Have a history of motion sickness or vertigo&#xD;
&#xD;
          -  Have active nausea or vomiting&#xD;
&#xD;
          -  Psychiatric conditions that may interfere with the ability to successfully participate&#xD;
             in the study&#xD;
&#xD;
          -  Have cardiac pacemakers&#xD;
&#xD;
          -  Require hearing aids at all times that cannot be removed&#xD;
&#xD;
          -  Have defibrillators&#xD;
&#xD;
          -  Have wound dressings on the head or neck that prevent comfortable use of the VR&#xD;
             headset&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan J Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>OHSU Knight Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OHSU Knight Cancer Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan J. Li</last_name>
      <phone>503-494-5355</phone>
      <email>lry@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Ryan J. Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>OHSU Knight Cancer Institute</investigator_affiliation>
    <investigator_full_name>Ryan Li, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

